ArticleFrontiers in oncology2023

Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review.

Bin Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.